Mark Lingen to Class I Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications Mark Lingen has written about Class I Phosphatidylinositol 3-Kinases.
Connection Strength
0.054
-
Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy. Cancer Lett. 2015 Apr 10; 359(2):269-74.
Score: 0.028
-
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. PLoS One. 2014; 9(3):e90171.
Score: 0.026